The Life Raft Group invites you to “IDRX-42: Trial Design and Emerging Data from the StrateGIST 1 Study”, on October 7th, 2024 at 1PM ET. During this educational webinar, Suzanne George, MD of the Dana-Farber Cancer Institute will review emerging data from the first-in-human StrateGIST 1 trial of IDRX-42 in patients with advanced GIST. Dr. George will also discuss the design and rationale for the ongoing Phase 1b portion of the trial, including first- and second-line cohorts. A Q&A session will follow the presentation.
Please email srothschild@liferaftgroup.org to submit a question ahead of the presentation.
Please note that this webinar is not a substitute for your physician’s guidance and care.
About Our Presenter
Dr. Suzanne George
Sarcoma Center at Dana-Farber Cancer Institute
Suzanne George, MD is the Division Chief of the Sarcoma Center at Dana-Farber Cancer Institute who leads a team focused on research and clinical care of patients with sarcomas and GIST. She has an extensive research experience in clinical trials and drug development and cares for patient from across New England, the US and internationally.
Thank you to our Webinar Sponsor!
